Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The FDA has declared the shortages as "resolved," removing the drugs from its shortage list
Primary analysis using trial product estimand found that bodyweight was significantly decreased in the active treatment groups
People with obesity also may have worse breast cancer outcomes compared to those without excess body weight
Most Common Uses Retatrutide, an investigational peptide, is gaining attention for its potential in treating metabolic disorders through its innovative triple-agonist mechanism, which simultaneously targets glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) receptors
Your body naturally produces GLP-1 after you eat
Beware of strictly online weight loss programs
US$ 29.12
US$ 26.74
US$ 23.06
US$ 22.21
US$ 26.99
US$ 28.31
US$ 21.15
US$ 21.34
US$ 24.29
US$ 28.50
